Notice of Intent VITROS Chemistry Analyzer.docx

This is a Notice of Intent to Sole Source announcing the Defense Health Agency's (DHA) plan to procure VITROS 5600 chemistry analyzers along with associated reagents, supplies, and support services. The DHA intends to sole source this requirement to Ortho Clinical Diagnostics, the manufacturer of the VITROS 5600 system, based on the medical necessity and operational requirements specific to DHA facilities. The sole source justification is based on the critical nature of clinical laboratory equipment standardization across Defense Health System facilities and the technical specifications unique to the VITROS 5600 platform that ensure compatibility with existing laboratory infrastructure and processes.

The notice serves as a pre-solicitation announcement providing vendors and interested parties with visibility into the DHA's acquisition plan. This Notice of Intent allows for a period during which parties may submit written objections or request consideration for alternative solutions before the formal solicitation is released. The procurement will include not only the analytical instruments themselves but also the complete ecosystem of reagents, consumable supplies, and ongoing technical support necessary for sustained operations. Interested parties should monitor for the formal solicitation release following the notice period.